SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Univec (UNVC)
UNVC 0.00270+3.8%9:33 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Phyco who started this subject8/14/2003 4:50:49 PM
From: scott_jiminez   of 181
 
A selloff in the shadow of the 10Q should not come as a shock.

The facts that 1. The new businesses acquired by UNVC appear to accretive, 2. The new Baltimore location and manufacturing facility was a one-time expense (while also FINALLY clearing up the seemingly endless syringe production problems); with this aspect of the business stabilized, there are greatly enhanced prospects for positive cash flow next FY and 3. the Chairman (Shoenfeld), President (Dalton), and some directors have purchased almost 19,000,000 shares of UNVC since January, 2002 (~15,000,000 since 09/02)...all these facts suggest the original impetus/perception for the run-up in the stock this year remains in place.

But there's no doubt that Univec's finances remain tenuous and while the potential rewards here have improved significantly over the past 12-18 months, the risks continue to be substantial.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News